Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.0K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.0K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

941
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
941
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

454
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
454
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

606
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
606
Neural Regulation01:37

Neural Regulation

40.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterizing the MRI signature of hippocampal sclerosis of aging.

Alzheimer's research & therapy·2026
Same author

Simultaneous LC-MS/MS quantification of free deoxyguanosines 2'-dG and 8-OHdG in ovine seminal plasma as biomarkers of oxidative DNA damage.

Frontiers in medicine·2026
Same author

Cognitive Testing in Spanish Older Adults: A Scoping Review.

Geriatrics (Basel, Switzerland)·2026
Same author

Identifying individuals at risk of cognitive decline: cross-sectional analysis of variability in neuropsychological test scores among community-dwelling older adults.

BMC public health·2026
Same author

Antioxidant Valorization of PLE Extracts from Macroalgae (<i>Cladophora glomerata</i>): In Vitro Assessment of Nanoemulsions Against Oxidative Stress.

Antioxidants (Basel, Switzerland)·2024
Same author

Impact of Iron Intake and Reserves on Cognitive Function in Young University Students.

Nutrients·2024

Related Experiment Video

Updated: Nov 2, 2025

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.4K

Neurodegenerative Diseases: A Multidisciplinary Approach.

Pilar Marcos-Rabal1, Joaquín González-Fuentes1, Lucía Castro-Vázquez1

  • 1Cellular Neurobiology and Molecular Chemistry of the Central Nervous System Group, Faculty of Medicine, Faculty of Pharmacy, and Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha, Albacete, Spain.

Current Pharmaceutical Design
|June 9, 2021
PubMed
Summary

Population aging drives a rise in dementia cases, complicating diagnosis due to mixed symptoms. This review covers dementia types, recent research, prevention, and nanotechnology for treatments.

Keywords:
Dementiaanalytical chemistrygenetic studiesnanotechnology.neuroimage techniquespreventive strategiesrodent models

More Related Videos

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

14.2K
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

17.7K

Related Experiment Videos

Last Updated: Nov 2, 2025

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.4K
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

14.2K
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

17.7K

Area of Science:

  • Neuroscience
  • Gerontology
  • Biomedical Engineering

Background:

  • Global population aging is increasing the incidence of neurodegenerative diseases, particularly dementias.
  • Dementia diagnosis is challenging due to multiple causes and overlapping symptoms in mixed dementia cases.
  • Personalized diagnosis and treatment require a comprehensive understanding of diverse dementia types.

Purpose of the Study:

  • To review the characteristics of major dementia types.
  • To compile recent research findings, including genetic, molecular, animal models, omics, and neuroimaging studies.
  • To discuss preventative measures and novel therapeutic strategies, such as nanotechnology.

Main Methods:

  • Literature review synthesizing current knowledge on dementia.
  • Inclusion of genetic, molecular, and animal model research.
  • Analysis of omics platforms and advanced neuroimaging techniques.
  • Consideration of modifiable risk factors and emerging technologies.

Main Results:

  • Dementia presents complex, often mixed, clinical pictures requiring multidisciplinary approaches.
  • Recent advances span genetic insights to sophisticated neuroimaging and omics data.
  • Preventive strategies focusing on modifiable factors like diet are crucial.
  • Nanotechnology offers potential for targeted drug delivery in dementia treatment.

Conclusions:

  • A comprehensive, multidisciplinary approach is essential for understanding and managing dementia.
  • Integrating diverse research findings and technologies is key to advancing dementia care.
  • Early detection, prevention, and innovative treatments are critical for addressing the growing dementia burden.